NCT00639353

Brief Summary

This study seeks to evaluate the clinical performance of a recently released contact lens designed to correct astigmatism to an established contact lens that has historically been used in these patients.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
102

participants targeted

Target at P50-P75 for not_applicable

Geographic Reach
1 country

10 active sites

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2008

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

March 14, 2008

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 20, 2008

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2008

Completed
Last Updated

October 29, 2014

Status Verified

October 1, 2014

Enrollment Period

4 months

First QC Date

March 14, 2008

Last Update Submit

October 28, 2014

Conditions

Outcome Measures

Primary Outcomes (2)

  • Subject-reported satisfaction for vision

    Scale of 0 to 100, were 0=extremely poor and 100=Excellent

    After 2 weeks of lens wear

  • Subject-reported satisfaction for comfort.

    Scale of 0 to 100, were 0=extremely poor and 100=Excellent

    After 2 weeks of lens wear

Secondary Outcomes (1)

  • Subject preference for lens type.

    After 2 weeks of lens wear.

Study Arms (2)

spherical contact lens

ACTIVE COMPARATOR

Subjects will wear and evaluate a spherical soft contact lens daily for 2 weeks

Device: senofilcon A sphere soft contact lens

toric contact lens

EXPERIMENTAL

Subjects will wear and evaluate a toric soft contact lens daily for 2 weeks

Device: senofilcon A toric soft contact lens

Interventions

contact lens

Also known as: ACUVUE OASYS for Astigmatism
toric contact lens

contact lens

Also known as: ACUVUE OASYS
spherical contact lens

Eligibility Criteria

Age18 Years - 39 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • The subject is 18 to 39 years of age. (Parental consent is required for a minor child i.e. under the age of 20.)
  • The subject has signed an informed consent with his/her own judgement for participation in the study.
  • The subject currently is a habitual wearer of spherical or toric daily-wear soft contact lenses, excluding daily disposables, in daily wear bases.

You may not qualify if:

  • The subject has any ocular or systemic allergies that interfere with contact lens wear.
  • The subject has dry eye and lacrimal apparatus disease that could interfere with contact lens wear.
  • The subject has any systemic disease or autoimmune disease that interferes with contact lens wear.
  • The subject has corneal edema, neovascularization, corneal staining or other ocular abnormalities (Grade 3 or above) that clinically apparently interfere with contact lens wear.
  • The subject has any anterior segment eye disease (palpebral abnormalities, corneal hypesthesia, corneal epithelial defect, bulbar conjunctival hyperemia, etc.) that clinically apparently interferes with contact lens wear.
  • The subject has a history of solution reactions to the chemical cleaner/disinfectant to be used in this study, as far as known to the subject.
  • The subject has ocular infection.
  • The subject has ocular inflammation (including acute/subacute anterior segment inflammations and uveitis).
  • The subject has corneal distortion resulting from previous experience of hard contact lens wear.
  • The subject has infectious disease (pneumonia, tuberculosis, etc.) or immunosuppressive disease (HIV positive etc.), as far as known to the subject.
  • The subject has diabetes, as far as known to the subject.
  • The subject is pregnant or in the lactation period, as far as known to the subject.
  • The subject uses any eye remedies (excluding artificial tear substitutes or hyaluronic acid drops for reducing dryness while wearing contact lenses).
  • The subject had any ocular trauma or surgery within 8 weeks prior to participation in the study.
  • The subject is a wearer of hard contact lenses (including rigid gas permeable).
  • +4 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (10)

Shioya eye clinic

Fukushima, Fukushima, Japan

Location

Takahashi eye clinic

Odawarashi, Kanagawa, Japan

Location

Kodama eye clinic

Jyoyoshi, Kyoto, Japan

Location

Inaba eye clinic

Osakashi, Osaka, Japan

Location

Iwasaki eye clinic

Osakashi, Osaka, Japan

Location

Watanabe eye clinic

Osakashi, Osaka, Japan

Location

Sakura eye clinic

Shizuoka, Shizuoka, Japan

Location

Kajita eye clinic

Minatoku, Tokyo, Japan

Location

Dogenzakaitoi eye clinic

Shibuyaku, Tokyo, Japan

Location

Ueda eye clinic

Shimonosekishi, Yamaguchi, Japan

Location

MeSH Terms

Conditions

Refractive ErrorsMyopiaAstigmatism

Condition Hierarchy (Ancestors)

Eye Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 14, 2008

First Posted

March 20, 2008

Study Start

February 1, 2008

Primary Completion

June 1, 2008

Last Updated

October 29, 2014

Record last verified: 2014-10

Locations